What the media is reporting about MassBio
News from the biotechnology industry
Showing news: 321–330 of 474
April 14, 2011 —
Semprus BioSciences is a venture-backed biomedical company spun out of MIT’s famed Langer lab four years ago. The company’s current focus is to develop a vascular access catheter with the first single surface modification that is designed to…
April 5, 2011 —
For anyone who attended this year's Rare Disease Day event at the State House, Gracie Van Brunt's musical performance was the highlight of the show!
Gracie has Schwachman-Diamond Syndrome, and wrote a song about what it is like to…
April 4, 2011 —
WASHINGTON, DC— U.S. Senators Scott Brown (R-MA) and Amy Klobuchar (D-MN) announced today that they will serve as co-chairs for the new Senate Medical Technology Caucus in the 112th Congress. The caucus aims to increase awareness about…
March 31, 2011 —
MassBio President & CEO Bob Coughlin joined Paul Guzzi and Mike Nikitas on This Week in Business to talk about Governor Deval Patrick's economic development trade mission to London and Israel. There are 1,000 opportunities for…
March 29, 2011 —
MassBio joined dozens of other organizations focused on protecting innovation in sending a letter to member of the U.S. House of Representatives, asking them to support patent reform legislation.
"Comprehensive patent reform will ensure that the…
March 25, 2011 —
Did you miss Personalized Medicine: Every Patient Tells a Story, the 2011 MassBio Annual Meeting?
Stay tuned for details on how to watch the panel sessions, keynote presentations and extra footage with meeting speakers online, thanks to our…
March 8, 2011 —
The Massachusetts Life Sciences Center is pleased to announce the launch of an open solicitation for uncommitted capital dollars for a period of three years beginning in FY13. The Center is interested in investing in high potential economic…
March 1, 2011 —
Biotechnology companies with fewer than 50 employees can now save 50% on MassBioEd job-related training programs for their employees.
Six MassBioEd courses have been accepted under the state’s Workforce Training Fund’s Express…
Millennium: The Takeda Oncology Company CEO Deborah Dunsire Named MassBio Innovative Leadership Award Recipient
February 28, 2011 —
Commitment to industry, growth, participation in Massachusetts cited in announcement
Deborah Dunsire, M.D., President & CEO of Millennium: The Takeda Oncology Company, has been chosen for this year’s MassBio Innovative Leadership…
February 28, 2011 —
More than a hundred patient advocates, biotechnology industry stakeholders and legislators gathered to mark the third annual Rare Disease Day at the State House today.
The last day of February has been designated as Rare Disease Day in…